The progress made in diagnosing and treating heart disease is remarkable. Patients are living longer, healthier lives thanks to greater awareness, preventative practices, and medical advances.
Below are some of Vanderbilt's cardiac technologies that could in the future have an impact on the detection and treatment of heart disease 
Assessment of Right Ventricular Function Using Contrast Echocardiography
New Drug for Blood Clot: FXII Inhibitors to Treat Thrombosis
Catheter Having Temperature Controlled Anchor and Related Methods
CTTC also assisted Vanderbilt researchers in launching two startup companies using cardiac related technologies developed at Vanderbilt.
InvisionHeart - an ECG System that enables healthcare professionals to read and visually compare, confirm, report, store and manage their ECGs.
VenoStent - a vein graft-supporting device made from a new class of shape-memory polymers.